Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Colorcon
AstraZeneca
Harvard Business School
Baxter

Last Updated: August 14, 2022

Investigational Drug Information for Nepadutant


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Nepadutant?

Nepadutant is an investigational drug.

There have been 4 clinical trials for Nepadutant. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2010.

The most common disease conditions in clinical trials are Colic, Digestive System Diseases, and Gastrointestinal Diseases. The leading clinical trial sponsors are Menarini Group and [disabled in preview].

Recent Clinical Trials for Nepadutant
TitleSponsorPhase
Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding IntoleranceMenarini GroupPhase 2
Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant With Colic Not Responding to Conventional TreatmentMenarini GroupPhase 2
Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant ColicMenarini GroupPhase 2

See all Nepadutant clinical trials

Clinical Trial Summary for Nepadutant

Top disease conditions for Nepadutant
Top clinical trial sponsors for Nepadutant

See all Nepadutant clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Colorcon
AstraZeneca
Harvard Business School
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.